Zerion Pharma A/S Financials, key figures and credit report
Net sales 3 377.6 kDKK FY 2025 -2.2% vs 2024
EBIT margin - 367.2 % FY 2025 +17.1 pp vs 2024
Net debt 7 994.9 kDKK FY 2025 +42.5% vs 2024
Quick ratio 2.9 FY 2025 +0.9 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 1 932.77 | 3 273.33 | 3 559.96 | 3 452.02 | 3 377.65 |
| Other operating income | 1 680.00 | 67.75 | 17.58 | ||
| Purchases during the financial year | -5 179.06 | -8 351.67 | -5 085.67 | -4 803.72 | -3 459.06 |
| External services | -5 148.39 | -5 902.06 | -3 727.68 | -4 482.58 | -4 727.75 |
| Gross profit | -6 714.67 | -10 912.65 | -5 253.39 | -5 834.28 | -4 791.58 |
| Employee benefit expenses | -6 245.37 | -9 538.15 | -6 156.56 | -6 896.75 | -7 076.09 |
| Total depreciation | - 219.90 | - 441.03 | - 537.20 | - 537.20 | - 536.54 |
| EBIT | -13 179.94 | -20 891.83 | -11 947.15 | -13 268.23 | -12 404.22 |
| Other financial income | 5.28 | 3.83 | 2.97 | 0.85 | 68.43 |
| Other financial expenses | - 571.13 | -1 241.10 | -1 561.47 | -1 592.57 | - 801.57 |
| Net income from associates (fin.) | 12 359.60 | ||||
| Pre-tax profit | -13 745.79 | -22 129.10 | -13 505.64 | -2 500.35 | -13 137.35 |
| Income taxes | 2 611.74 | 3 271.78 | 2 403.75 | 2 280.33 | 2 307.00 |
| Net earnings | -11 134.05 | -18 857.32 | -11 101.89 | - 220.02 | -10 830.35 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 2 114.47 | 2 945.73 | 2 625.90 | 2 088.70 | 1 552.16 |
| Tangible assets total | 2 114.47 | 2 945.73 | 2 625.90 | 2 088.70 | 1 552.16 |
| Other shares and similar rights of ownership | 20.00 | 20.00 | |||
| Investments total | 158.49 | 158.49 | |||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 595.01 | 818.19 | 492.33 | 184.61 | 1 007.80 |
| Current amounts owed by group member comp. | 677.86 | 1 709.87 | |||
| Prepayments and accrued income | 578.73 | 76.18 | 443.96 | 369.71 | |
| Current other receivables | 1 153.18 | 1 161.76 | 467.83 | 299.90 | 316.88 |
| Current deferred tax assets | 2 611.74 | 3 393.96 | 2 510.00 | 2 350.99 | 2 307.02 |
| Short term receivables total | 4 938.67 | 5 373.91 | 3 546.33 | 3 957.31 | 5 711.28 |
| Cash and bank deposits | 6 644.49 | 4 103.62 | 2 299.97 | 3 466.60 | 3 632.96 |
| Cash and cash equivalents | 6 644.49 | 4 103.62 | 2 299.97 | 3 466.60 | 3 632.96 |
| Balance sheet total (assets) | 13 697.62 | 12 423.25 | 8 472.21 | 9 671.10 | 11 054.90 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 459.48 | 520.93 | 640.02 | 907.26 | 1 024.86 |
| Other reserves | 904.53 | ||||
| Retained earnings | 9 807.74 | 8 378.31 | -3 268.64 | -2 945.71 | 5 389.55 |
| Profit of the financial year | -11 134.05 | -18 857.32 | -11 101.89 | - 220.02 | -10 830.35 |
| Shareholders equity total | - 866.83 | -9 958.08 | -13 730.51 | -2 258.47 | -3 511.41 |
| Non-current loans from credit institutions | 10 403.83 | 17 768.02 | 19 196.38 | 8 051.67 | 11 180.18 |
| Non-current deferred tax liabilities | 175.65 | 181.00 | 187.70 | 193.52 | 199.32 |
| Non-current liabilities total | 10 579.47 | 17 949.02 | 19 384.08 | 8 245.19 | 11 379.50 |
| Current loans from credit institutions | 837.99 | 922.49 | 1 025.36 | ||
| Current trade creditors | 2 366.48 | 1 987.24 | 1 536.08 | 1 304.30 | 1 467.94 |
| Current owed to participating | 447.63 | ||||
| Other non-interest bearing current liabilities | 1 618.50 | 1 607.08 | 360.07 | 1 354.73 | 1 271.23 |
| Current liabilities total | 3 984.98 | 4 432.31 | 2 818.64 | 3 684.38 | 3 186.80 |
| Balance sheet total (liabilities) | 13 697.62 | 12 423.25 | 8 472.21 | 9 671.10 | 11 054.90 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated